Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Mary Welch, MD
Phone
1 646 957 2423
Email
mw2517@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Welch:
More InfoTitleSponsorIRB Number
DetailsINdividualized Screening trial of Innovative Glioblastoma Therapy (INSIGhT)Dana-Farber Cancer InstituteAAAR5763
DetailsStudy of DSP-7888 in Combination with Bevacizumab in Patients with Recurrent or Progressive GlioblastomaBoston Biomedical, Inc.AAAR4631
DetailsCollection of Tissue and Medical Information from Research Subjects with Neurological DisordersDana Farber Cancer InstituteAAAR5764
DetailsStudy Treatment (INO-5401 and INO-9012 delivered by electoporation device in combination with REGN2810) in Subjects with GlioblastomaInovio Pharmaceuticals, Inc.AAAR8166
Details[CLOSED] Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with High-Grade Glioma (HGG)Alliance for Clinical Trials in OncologyAAAR9176
Details[CLOSED] Study of Cediranib and Olaparib Compared to Bevacizumab in Patients with Recurrent GlioblastomaNational Cancer InstituteAAAR9182
DetailsCB-839 With Radiation Therapy and Temozolomide in Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic AstrocytomaNational Cancer Institute NCIAAAS3546